Results for tag: "Dabigatran Testing"

The Dabigatran Testing market is a segment of the Diagnostics industry that focuses on the detection of dabigatran, a direct thrombin inhibitor used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation. Dabigatran Testing is used to measure the concentration of dabigatran in the blood, which is important for determining the correct dosage and monitoring the effectiveness of the drug. The market is composed of a variety of products, including point-of-care tests, laboratory tests, and home-use tests. Some of the companies in the Dabigatran Testing market include Siemens Healthineers, Abbott, Roche Diagnostics, and Alere. Show Less Read more